DIFFUSE LARGE B CELL LYMPHOMA
Clinical trials for DIFFUSE LARGE B CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new DIFFUSE LARGE B CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for DIFFUSE LARGE B CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental lymphoma drug trial halted early
Disease control TerminatedThis study tested an experimental drug called SAR444245, both alone and combined with other cancer treatments, for people with advanced B-cell lymphoma that had returned or stopped responding to previous therapies. It involved 14 participants aged 12 and older who had already tri…
Matched conditions: DIFFUSE LARGE B CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Early-Stage trial halted for aggressive blood cancer treatment
Disease control TerminatedThis early-stage study tested a combination of three medicines for people with an aggressive type of blood cancer called diffuse large B-cell lymphoma that had returned or stopped responding to prior treatment. The trial was for patients who could not receive a stem cell transpla…
Matched conditions: DIFFUSE LARGE B CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Targeted immunotherapy tested for Tough-to-Treat lymphoma
Disease control TerminatedThis study tested whether the immunotherapy drug pembrolizumab could help adults with a specific type of aggressive lymphoma that had returned or not responded to prior treatments. It focused on patients whose lymphoma cells had a particular genetic change (PD-L1 alteration). The…
Matched conditions: DIFFUSE LARGE B CELL LYMPHOMA
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC